ERBB2 and cancer: Further studies will focus on gaining a more detailed understanding of why the reprogramming of FA uptake induces plasticity in HER2 + mammary tumor cells, leading to the intratumor enrichment of EMT-like CD36+ /HER2 + cancer stem cells (CSCs).